Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers' needs from research to final product manufacture. Lonza's Bioscience Division provides innovative, reliable research products and services for cell culture, cell biology and molecular biology. With the July 2008 acquisition of the Cologne (Germany) based amaxa AG, now Lonza Cologne AG, Lonza is able to provide researchers in academic, governmental and private institutions, as well as in biotech and pharmaceutical companies, with primary cells, matched cell culture media and reagents, and the capability to transfect those cells via Nucleofector® Technology.
Using Nucleofection®, cell lines, as well as primary cells and stem cells, can be reliably transfected at ...
